We report on coding methods for efficiently synthesizing deoxyribonucleic acid (DNA) for massive data storage, where a plurality of DNA strands are synthesized in parallel. We examine the trade-offs ...

Reliable representation of the B-DNA base-pair step twist is one of the crucial requirements for theoretical modeling of DNA supercoiling and other biologically relevant phenomena in B-DNA. It has ...

Twist Bioscience Corporation’s stock is down 22.7% in 2025, up 3.7% in the previous five trading days and down 24.88% in the past year. Currently, Twist Bioscience Corporation does not have a ...

When Twist Bioscience last reported its March 2025 balance sheet in May 2025, it had zero debt and cash worth US$257m. Importantly, its cash burn was US$65m over the trailing twelve months.

How Well Is Twist Bioscience Growing? We reckon the fact that Twist Bioscience managed to shrink its cash burn by 31% over the last year is rather encouraging. And considering that its operating ...

Review the current valuation for Twist Bioscience Corp (TWST:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.